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A B S T R A C T  
Background: The incidence of squamous cell carcinoma has doubled in the last three decades associated with a high 
rate of morbidity and mortality. The incidence of bleeding and/or thrombosis in advanced stage cancer necessitates a 
need for research in blood coagulation abnormalities in malignancy. The objective of the present study was to 
determine the alteration in coagulation pattern among patients diagnosed with squamous cell carcinoma (SCC). 
Material and Methods: This cross-sectional study was conducted in Pathology department of Isra University Hospital, 
Hyderabad over a period of 06 months. A total of 126 samples were selected through non-probability convenient 
sampling. Both male and female patients of all age groups having SCC of skin, gastrointestinal and genital tract were 
included. The coagulation profile was analyzed by Sysmax CA 50 and Nycocard reader II. Data was entered into SPSS 
version 22.0 and results were analyzed. 
Results: The mean age of the patients with SCC in the present study was 55.5 ± 12 years with more male patients 
(n=81; 64.3%) as compared to females (n=45; 35.7%). Oral SCC was found to be the most common site of squamous 
cell carcinoma (43.7%). Majority of the patients had well differentiated SCC (42.1%) followed by moderately 
differentiated (40.5%) and poorly differentiated SCC (17.4%). The comparison of severity of SCC with coagulation 
profile revealed that PT (P=0.01), APTT (P=0.001), D-dimers (P=0.01 and TT (P=0.01) were significantly increased, 
whereas fibrinogen was significantly decreased (P=0.001). 
Conclusions: The histological differentiation of SCC (from well differentiated to poorly differentiated tumors) showed 
a highly significant association with different coagulation profile parameters like PT, APTT, BT, CT, D-dimer, TT, and 
fibrinogen levels. 
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I n t r o d u c t i o n  
 
Squamous cell carcinoma is the second most 
common malignancy of skin. It also arises from 
head and neck, vagina, cervix and anus.
1 
The 
prostate, urinary bladder, esophagus and lung are 
ORIGINAL ARTICLE 
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further possible locations.
2 
The incidence of 
squamous cell carcinoma has doubled in the last 
three decades in United States and approximately 
2% of those affected die from this disease.
2 
Most of 
the cases of oral and throat SCC are diagnosed at a 
late stage. The prevalence of SCC is higher in 
Pakistan and other South East Asian nations.
3 
Risk 
of this cancer is intensified by direct and prolonged 
exposure to sunlight.
4 
Patients presenting with 
squamous cell carcinoma unveil discrepancies in 
their signs and symptoms and response to 
treatment. The common age at diagnosis of SCC of 
skin is 8th decade of life.
5
 Males are more affected 
by this disease as compared to females. Like any 
malignancy, it affects bone marrow and decreases 
hemopoiesis as well. Fibrinolytic system is activated 
in SCC cases at subclinical and clinical stages.  The 
biological consequences of the haemostatic 
deviations in squamous cell carcinoma are 
imprecise. There is evidence that malignant cells 
activate the coagulation system with an increase in 
fibrinolytic activity. This may result in increased 
metastatic activities leading to DIC.
6
 So it is 
multifaceted interaction between pathologic 
mechanism of thrombosis, tumor cells and 
haemostatic system.
7 
Plasma concentration of D-
dimer is increased in malignancy due to activation 
of fibrinolytic system.
8 
Raised levels of prothrombin 
time (PT), Activated partial thromboplastin time 
(APTT), thrombin time (TT), low Anti thrombin-III 
activity and increased fibrin degradation products 
(FDP) indicates disseminated intravascular 
coagulation.
9-11 
Tumor cells lead to activation of 
coagulation system either directly, by release of 
procoagulants from tumor cells, or indirectly, 
through production of tumor cells cytokines that 
trigger procoagulant substances in the systemic 
circulation by monocytes, macrophages and 
endothelial cells.
12
 
The bleeding and/or thrombosis in advanced stage 
cancer provides need for a research in blood 
coagulation abnormalities in malignancy. This study 
is intended to detect coagulation abnormalities 
that lead to disseminated intravascular coagulation 
and might predict hemorrhagic or thrombotic 
complications.
13 
Thromboembolic disease is a 
common complication of malignancy which occurs 
due to disturbance in haemostatic balance 
comprising interactions between endothelial cells, 
thrombocytes, coagulation, and fibrinolysis. Lack of 
early and prompt diagnosis of DIC leads to 
development of lethal complications and bleeding 
diathesis. Therefore, DIC screening is associated 
with a reduction in mortality in patients presenting 
with sepsis. The aim of this study was to determine 
the relationship between the hematological and 
coagulation parameters with various morphological 
grades of squamous cell carcinoma. 
M a t e r i a l  a n d  M e t h o d s  
This cross-sectional study was conducted in the 
Pathology department of Isra University Hospital. 
Both male and female patients of all age groups 
having SCC of skin, gastrointestinal and genital tract 
were selected through non probability convenient 
sampling. Study duration was 6 months from May 
2017 to October 2017. Patients with chronic co-
morbidities like skin infections, congenital 
haematological abnormalities and those on 
chemotherapy were excluded.  
Using aseptic techniques, approximately 3ml whole 
blood was collected by venipuncture in citrated 
bottles. Plasma was separated by centrifuging at 
2000 rpm for 10 minutes, and stored at -24˚C until 
analysis. The coagulation profile was analyzed by 
Sysmax ca 50 coagulation analyzer and NycoCard 
Reader II. 
Data was analyzed using SPSS version 22.0. 
Frequency and percentages were calculated for 
qualitative variables. ANOVA test was applied for 
comparison of more than 2 variables like 
prothrombin time (PT), Activated partial 
thromboplastin time (APTT), thrombin time (TT), 
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Anti thrombin-III activity and D-dimers. P-value 
<0.05 was taken as statistically significant. 
R e s u l t s  
In this study mean age of the patients was 55.5 ± 12 
years, with an age range of 23 - 80 years.  Most of 
the patients were males (n=81; 64.3%) as compared 
to females (n=45; 35.8%). Majority of the patients 
were found with well differentiated (42.1%) and 
moderately differentiated SCC (40.5%), while 
poorly differentiated SCC was found only in 17.4%. 
Oral SCC (43.7%) was the most common site of 
squamous cell carcinoma followed by esophageal 
SCC (28.6%) (Table I). 
Table I: Distribution of squamous cell carcinoma 
cases according to site (n=126) 
Site n (%) 
Oral cavity 55 (43.7) 
Esophagus 36 (28.6) 
Skin 14 (11.1) 
Cervix 13 (10.3) 
Anus 5 (3.9) 
Vagina 3 (2.3) 
 
The coagulation profile comprising the PT, APTT, 
clotting time, bleeding time, D-dimer, fibrinogen 
and thrombin time was compared with histological 
grades of SCC (Table II). The mean prothrombin 
time increased significantly from 15.22 ± 3.71 
seconds in well differentiated SCC to 24.01 ± 2.9 
seconds in poorly differentiated squamous cell 
carcinoma (P=0.01). Similarly, the mean APTT 
(P=0.001), bleeding time (P=0.05), clotting time 
(P=0.05), thrombin time (P=0.01) and D-Dimers 
(P=0.01) showed a significant increase from well 
differentiated SCC to poorly differentiated SCC 
(Table II). However, Fibrinogen levels decreased as 
tumor progressed from well differentiated to 
poorly differentiated grade (P=0.001) (Table II). 
 
 
D i s c u s s i o n  
In this study, the coagulation profile (PT, APTT, BT, 
CT, TT, fibrinogen, D-dimer) is found deranged in 
accordance with the different histological grades of 
SCC. The deranged values were more pronounced 
in poorly differentiated squamous cell carcinoma. 
These results are in accordance with the study 
conducted by Tas et al
15 
who reported elevated 
plasma levels of D-dimer, fibrinogen, PT, APTT and 
INR in lung cancer patients. In the present study, 
significant alteration was seen in BT and CT, which 
is parallel with the study conducted by Engheta et 
al.
16 
who also conveyed similar findings. Zhang et al. 
and Li et al. reported that the triggered hemostatic 
system for instance, hyperfibrinogenemia and 
higher D-dimer levels are found in SCC which is 
parallel with the present revision.
17,18
 Studies by Liu 
et al. and Feng et al.
 
also found increased plasma 
levels of D-dimer in SCC patients, which is 
consistent with the current study.
19,20
 However, the 
current study also assessed the D-dimer levels in 
squamous cell carcinoma patients on the basis of 
grading. 
Study conducted by Nakano et al. altered levels of 
blood coagulation factors in different pathologic 
types of lung cancer.
21
 In addition fibrin/fibrinogen 
degradation products, fibrinogen, and D-dimer 
levels differed significantly between cancer patients 
and the control group. These findings are 
consistent with our study which also showed raised 
level of D-dimer and PT in different histopathologic 
types of squamous cell carcinoma.  
The result of the present study shows significantly 
increased levels of D-dimer in different histologic 
types of squamous cell carcinoma. These findings 
are similar to a study by Luo et al who also reported 
increased level of D-dimer for different histologic 
grades of squamous cell carcinoma.
22 
Mariani et al.
 
also showed raised levels of PT, APTT, and TT 
indicating hypercoagulability with significantly  
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Table II: Comparison of coagulation profile with histological grades of squamous cell carcinoma (n=126) 
Groups Prothrombin Time F-value P-value* 
WD vs MD 15.22±3.71 16.33±2.55 
4.49 
0.82 
WD vs PD 15.22±3.71 24.01±2.90 0.01 
PD vs MD 24.01±2.90 16.33±2.55 0.03 
 
WD vs MD 
APTT 
7.49 
 
0.08 35.10±9.10 37.36±13.89 
WD vs PD 35.10±9.10 43.39±13.68 0.001 
PD vs MD 43.39±13.68 37.36±13.89 0.01 
 
WD vs MD 
Bleeding Time 
2.60 
 
0.01 3.40±0.73 5.44±0.63 
WD vs PD 3.40±0.73 6.17±0.42 0.05 
PD vs MD 6.17±0.42 5.44±0.63 0.82 
 
WD vs MD 
Clotting Time 
2.58 
 
0.99 4.88±0.89 5.22±1.25 
WD vs PD 4.88±0.89 6.93±1.32 0.05 
PD vs MD 6.93±1.32 5.22±1.25 0.72 
 
WD vs MD 
D-Dimers 
2.49 
 
0.82 
0.74±0.16 0.83±0.23 
WD vs PD 0.74±0.16 1.01±0.31 0.01 
PD vs MD 1.01±0.31 0.83±0.23 0.03 
 
WD vs MD 
Fibrinogen 
5.46 
0.05 
174.75±20.8 186.58±18.1 
WD vs PD 174.75±20.8 227.9±22.1 0.001 
PD vs MD 227.9±22.1 186.58±18.1 0.001 
 
WD vs MD 
Thrombin Time 
2.09 
 
0.08 50.11±7.92 45.18±6.68 
WD vs PD 50.11±7.92 82.51±5.74 0.01 
PD vs MD 82.51±5.74 45.18±6.68 0.01 
 
*P-value <0.05 was considered statistically significant. 
WD=Well-differentiated, MD=Moderately-differentiated, 
PD=Poorly-differentiated, vs=versus, APTT=activated 
partial thromboplastin time 
F-value = used in analysis of variance (ANOVA) to 
determine whether the test is statistically significant 
decreased levels of platelets in lung cancer 
patients.
23 
The D-dimer levels remained unchanged. 
These findings are consistent with our study, except 
D-dimer, as all the coagulation markers significantly 
increased as the severity of histological grade of 
squamous cell carcinoma increased from well 
differentiated to poorly differentiated cancer. 
 
The main limitation of this study was that 
immunomarkers for confirmation of doubtful cases 
were not applied due to financial constraints. 
Another limitation was that the results cannot be 
generalized as comparatively lower number of SCC 
cases were studied with an unequal distribution of 
cancers arising from different sites. 
C o n c l u s i o n  
The different coagulation profile parameters like 
PT, APTT, BT, CT, D-dimer and TT are elevated in 
SCC, with a decrease in fibrinogen levels, 
proportional to the severity of the histological 
grade. 
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Recommendations: Changes in hemostasis play an 
important role in anticipation of future 
hemorrhagic manifestation and thrombotic event 
during cancer progression. Early workup for 
presence of coagulation abnormalities will prevent 
mortality and other bleeding diathesis in cancer, as 
alterations in coagulation pathway leads to lethal 
complication of hemostasis. 
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